Partner with us for Innovate UK's
Smart Grants: August 2020
We can help bring your game-changing, innovative and disruptive ideas towards commercialisation.
© Medicines Discovery Catapult 2020. All rights reserved.
Get in touch to discuss your application
We’ll use the data you give us to manage and report on our engagement with you, your organisation, and the wider industry. For more details read our Privacy Policy.
We have connections across industry, academia, finance, government, and research networks
Our experienced team have a wealth of commercial, industrial, and academic grant writing expertise
We can give you supported access to groundbreaking technologies with independent, specialist expertise and advice
There are great reasons to apply with us...
Meet our Grants team
Dr Rachel Lawless, Grants Officer
Rachel gained a MRes and a PhD in musculoskeletal ageing at the University of Liverpool. Following this she took post-doctoral positions identifying the role of microRNAs in muscle and using materials as a treatment for aged-related macular degeneration. During this time, she was also a council member at The Physiological Society. Rachel has wide experience in writing academic grants and since moving to MDC at the beginning of 2020 writes business grants for organisations large and small.
Dr Marc Daigneault, Head of Research Funding
Marc is responsible for business engagement, development and exploitation. He has a strong academic record across a range of disciplines, including infection and immunity, cell signalling, cardiovascular disease and biomaterials. For the past 5 years, Marc has worked as a business development and innovation professional supporting SMEs in raising over £30 million in non-dilutive funding and £150 million in venture capital. At MDC, Marc supports a current portfolio of >30 UK-based SMEs in biopharma with business model development, route to market and exploitation planning.
Project awarded £3.14 million under Innovate UK Biomedical Catalyst programme, to develop next-generation anticoagulant
£516k grant for biomarker project which aims to accelerate therapeutic development for idiopathic pulmonary fibrosis
£370k funded project to address the need for more accessible AI and data in the B2B marketplace – prioritising drug discovery, diagnostics and clinical trials
Read about our grant successes
Organisation: Innovate UK
Opportunity for UK registered organisations to apply for a share of up to £25 million from Innovate UK to deliver disruptive R&D innovations that can significantly impact the UK economy.
Competition opens: Friday 28 August 2020
Competition closes: Wednesday 25 November 2020
Competition details